Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women
Status:
Completed
Trial end date:
2020-03-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether increasing the dose of the levonorgestrel
subdermal contraceptive implant will overcome a detrimental drug-drug interaction with
efavirenz based antiretroviral therapy.
Phase:
Phase 2
Details
Lead Sponsor:
University of Nebraska
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Feinberg School of Medicine, Northwestern University Infectious Diseases Institute, Uganda University of Liverpool